Innovative nanocompounds for cutaneous administration of classical antifungal drugs: a systematic review

References

• Dou Y-H, Du J-K, Liu H-L, et al. The role of procalcitonin in the identification of invasive fungal infection – a systemic review and meta-analysis. Diagn Microbiol Infect Dis. 2013;76:464.
   PubMed Web of Science ®Google Scholar
• Shao P-L, Huang L-M, Hsueh P-R. Recent advances and challenges in the treatment of invasive fungal infections. Int J Antimicrob Agents. 2007;30:487.
   PubMed Web of Science ®Google Scholar
• de Oliveira COP, de Souza NL, da Silva EMM, et al. Revista Enfermagem. UERJ. 2013;21:90.
   Google Scholar
• Amorim A, Guedes-Vaz L, Araujo R. Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy. Int J Antimicrob Agents. 2010;35:396.
   PubMed Web of Science ®Google Scholar
• Deepak R, Ponnusami V, Jayapradha R. Response surface methodology: optimisation of antifungal bioemulsifier from novel Bacillus thuringiensis. Sci World J. 2014;2014:423289.
   Google Scholar
• Yoon M-Y, Kim YS, Ryu SY, et al. In vitro and in vivo antifungal activities of decursin and decursinol angelate isolated from Angelica gigas against Magnaporthe oryzae, the causal agent of rice blast. Pest Biochem Physiol. 2011;101:118.
   Web of Science ®Google Scholar
• Joseph-Horne T, Manning N, Holoman D, et al. Nonsterol related resistance in Ustilago maydis to the polyene antifungals, amphotericin B and nystatin. Phytochemistry. 1996;42:637.
   PubMed Web of Science ®Google Scholar
• Perez-Nadales E, Nogueira MFA, Baldin C, et al. Fungal model systems and the elucidation of pathogenicity determinants. Fungal Genet Biol. 2014;70:42.
   PubMed Web of Science ®Google Scholar
• Richter SS, Galask RP, Messer SA, et al. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol. 2005; 43:2155.
   PubMed Web of Science ®Google Scholar
• Serhan G, Stack CM, Perrone GG, et al. The polyene antifungals, amphotericin B and nystatin, cause cell death in Saccharomyces cerevisiae by a distinct mechanism to amphibian-derived antimicrobial peptides. Ann Clin Microbiol Antimicrob. 2014;13:18.
   PubMed Web of Science ®Google Scholar
• Watson M, Grimshaw J, Bond CM, et al. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev. 2001;(3).
   Google Scholar
• Denning DW. Echinocandin antifungal drugs. Lancet. 2003;362:1142.
   PubMed Web of Science ®Google Scholar
• Khan ZUH, Khan AU, Wan P, et al. In vitro pharmacological screening of three newly synthesised pyrimidine derivatives. Nat Prod Res. 2015;29:933.
   PubMed Web of Science ®Google Scholar
• Ceruso M, Carta F, Osman SM, et al. Inhibition studies of bacterial, fungal and protozoan β-class carbonic anhydrases with Schiff bases incorporating sulfonamide moieties. Bioorg Med Chem. 2015;23:4181.
   PubMed Web of Science ®Google Scholar
• Akhtar N, Verma A, Pathak K. Topical delivery of drugs for the effective treatment of fungal infections of skin. Curr Pharm Des. 2015;21:2892.
   PubMed Web of Science ®Google Scholar
• Vazquez JA. Infection due to non-candidal yeasts. In: Diagnosis and treatment of fungal infections; 2015. p. 119–128.
   Google Scholar
• Ribeiro Rosa EA. (Ed.). (2015). Oral candidosis: physiopathology, decision making, and therapeutics. Berlin: Springer-Verlag.
   Google Scholar
• Zonios D, Yamazaki H, Murayama N, et al. Voriconazole metabolism, toxicity, and the effect of cytochrome P450 2C19 genotype. J Infect Dis. 2014;209:1941.
   PubMed Web of Science ®Google Scholar
• Hussain A, Samad A, Nazish I, et al. Nanocarrier-based topical drug delivery for an antifungal drug. Drug Dev Indus Pharm. 2014;40:527.
   PubMed Web of Science ®Google Scholar
• Amaral AC, Felipe MSS. Nanotechnological strategies to improve antifungal therapy. Rec Patent Nanomed. 2013;3:56.
   Google Scholar
• Tang X, Zhu H, Sun L, et al. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo. Int J Nanomedicine. 2014;9:5403.
   PubMed Web of Science ®Google Scholar
• Eldridge ML, Chambers CJ, Sharon VR, et al. Fungal infections of the skin and nail: new treatment options. Expert Rev Anti Infect Ther. 2014;12:1389.
   PubMed Web of Science ®Google Scholar
• Varon AG, Nouer SA, Barreiros G, et al. Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis. J Infect. 2014;68:85.
   PubMed Web of Science ®Google Scholar
• Salvatori G, Carminati P, Romani L. Google Patents. 2014.
   Google Scholar
• Galhardo MC, De Oliveira RM, Valle AC, et al. Molecular epidemiology and antifungal susceptibility patterns of Sporothrix schenckii isolates from a cat-transmitted epidemic of sporotrichosis in Rio de Janeiro, Brazil. Med Mycol. 2008;46(2):141–151.
   PubMed Web of Science ®Google Scholar
• Neumann A, Baginski M, Czub J. How do sterols determine the antifungal activity of amphotericin B? Free energy of binding between the drug and its membrane targets. J Am Chem Soc. 2010;132:18266.
   PubMed Web of Science ®Google Scholar
• Bell-Syer SE, Khan SM, Torgerson DJ. Oral treatments for fungal infections of the skin of the foot. Sao Paulo Med J. 2014;132:127.
   PubMed Web of Science ®Google Scholar
• Costa RO, Macedo PM, Carvalhal A, et al. Use of potassium iodide in dermatology: updates on an old drug. Anais Brasileiros de Dermatologia. 2013;88(3):396–402.
   PubMed Web of Science ®Google Scholar
• Eschenauer G, De Pestel DD, Carver PL. Comparison of echinocandin antifungals. Ther Clin Risk Manag. 2007;3:71.
   PubMedGoogle Scholar
• Souto EB, Muller RH. The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents. Pharmazie. 2006;61:431
   PubMed Web of Science ®Google Scholar
• Moudgal VV, Sobel JD. Antifungal drugs in pregnancy: a review. Expert Opin Drug Saf. 2003;2:475.
   PubMedGoogle Scholar
• Pilmis B, Jullien V, Sobel J, et al. Antifungal drugs during pregnancy: an updated review. J Antimicrob Chemother. 2015;70:14.
   PubMed Web of Science ®Google Scholar
• Sapra A, Kumar P, Kakkar S, et al. Synthesis, antimicrobial evaluation and QSAR studies of p-hydroxy benzoic acid derivatives. Drug Res. 2014;64:17.
   Google Scholar
• Zhao M, Hu J, Zhang L, et al. Study of amphotericin B magnetic liposomes for brain targeting. Int J Pharm. 2014;475:9.
   PubMedGoogle Scholar
• Mikawlrawng K, Kaushik S, Pushker A, et al. Comparative in vitro antifungal activities of Simarouba glauca against Fusarium oxysporum and Aspergillus parasiticus. J Med Plant Stud. 2014;2:1–7.
   Google Scholar
• Cassano R, Ferrarelli T, Mauro MV, et al. Preparation, characterization and in vitro activities evaluation of solid lipid nanoparticles based on PEG-40 stearate for antifungal drugs vaginal delivery. Drug Deliv. 2016;23:1037–1046.
   Web of Science ®Google Scholar
• Imbert S, Palous M, Meyer I, et al. In vitro combination of voriconazole and miltefosine against cinically relevant molds. Antimicrob Agents Chemother. 2014;58:6996–6998.
   PubMed Web of Science ®Google Scholar
• Kote SR, Mishra R, Khan AA, et al. Synthesis and cytotoxic evaluation of novel 2,3-di-O-alkyl derivatives of l-ascorbic acid. Med Chem Res. 2014;23:1257.
   Google Scholar
• Ellepola AN, Khan ZU, Joseph B, et al. Prevalence of Candida dubliniensis among oral Candida isolates in patients attending the Kuwait University Dental Clinic. Med Princ Pract. 2011;20:271–276.
   PubMed Web of Science ®Google Scholar
• Darwish ES, Fattah AMA, Attaby FA, et al. Synthesis and antimicrobial evaluation of some novel thiazole, pyridone, pyrazole, chromene, hydrazone derivatives bearing a biologically active sulfonamide moiety. Int J Mol Sci. 2014;15:1237.
   PubMed Web of Science ®Google Scholar
• Soares LA, Sardi JDCO, Gullo FP, et al. Anti dermatophytic therapy: prospects for the discovery of new drugs from natural products. Braz J Microbiol. 2013;44:1035–1041.
   PubMed Web of Science ®Google Scholar
• Alvarado HL, Abrego G, Souto EB, et al. Nanoemulsions for dermal controlled release of oleanolic and ursolic acids: in vitro, ex vivo and in vivo characterization. Colloids Surf B Biointerfaces. 2015;130:40.
   PubMed Web of Science ®Google Scholar
• Clares B, Calpena AC, Parra A, et al. Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation. Int J Pharm. 2014;473:591.
   PubMed Web of Science ®Google Scholar
• Souto EB, Muller RH. SLN and NLC for topical delivery of ketoconazole. J Microencapsul. 2005;22:501.
   PubMed Web of Science ®Google Scholar
• Souto EB, Muller RH. Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams. Pharmazie. 2007;62:505.
   PubMed Web of Science ®Google Scholar
• Alomrani AH, Shazly GA, Amara AA, et al. Itraconazole-hydroxypropyl-β-cyclodextrin loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model. Colloids Surf B Biointerfaces. 2014;121:74.
   PubMed Web of Science ®Google Scholar
• Elmoslemany RM, Abdallah OY, El-Khordagui LK, et al. Propylene glycol liposomes as a topical delivery system for miconazole nitrate: comparison with conventional liposomes. AAPS PharmSciTech. 2012;13:723.
   PubMed Web of Science ®Google Scholar
• Mitkari BV, Korde SA, Mahadik KR, et al. Formulation and evaluation of topical liposomal gel for fluconazole. Indian J Pharm Educ Res. 2010;44(4):324–333.
   Web of Science ®Google Scholar
• Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharma. 2001;228(1-2):43–52.
   PubMed Web of Science ®Google Scholar
• Singh A, Rathore P, Shukla M, et al. Comparative studies on skin permeation of miconazole using different novel carriers. Int J Pharm Sci Res. 2010;1(9):61–66.
   Google Scholar
• Bhalaria MK, Naik S, Misra AN. Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. Indian J Exp Biol. 2009;47:368.
   PubMed Web of Science ®Google Scholar
• Verma P, Pathak K. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine. 2012;8:489.
   PubMed Web of Science ®Google Scholar
• Pandit J, Garg M, Jain NK. Miconazole nitrate bearing ultraflexible liposomes for the treatment of fungal infection. J Liposome Res. 2014;24:163.
   PubMed Web of Science ®Google Scholar
• Guo F, Wang J, Ma M, et al. Skin targeted lipid vesicles as novel nano-carrier of ketoconazole: characterization, in vitro and in vivo evaluation. J Mater Sci Mater Med. 2015;26:1.
   Web of Science ®Google Scholar
• Sudhakar B, Ravi Varma JN, Ramana Murthy KV. Formulation, characterization and ex vivo studies of terbinafine HCl liposomes for cutaneous delivery. Curr Drug Deliv. 2014;11(4):521–530.
   PubMed Web of Science ®Google Scholar
• El-Badry M, Fetih G, Shakeel F. Comparative topical delivery of antifungal drug croconazole using liposome and micro-emulsion-based gel formulations. Drug Deliv. 2014;21:34.
   PubMed Web of Science ®Google Scholar
• Patel RP, Patel G, Patel H, et al. Formulation and evaluation of transdermal patch of aceclofenac. Res J Pharma Dosage Forms Technol. 2009;1(2):108–115.
   Google Scholar
• Souto EB, Wissing SA, Barbosa CM, et al. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 2004;278:71.
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu D, Liu J, et al. Development of terbinafine solid lipid nanoparticles as a topical delivery system. Int J Nanomedicine. 2012;7:4409.
   PubMed Web of Science ®Google Scholar
• Gokce EH, Sandri G, Bonferoni MC, et al. Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity. Int J Pharm. 2008;364:76.
   PubMed Web of Science ®Google Scholar
• Jain S, Jain S, Khare P, et al. Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug Deliv. 2010;17:443.
   PubMed Web of Science ®Google Scholar
• Gupta M, Tiwari S, Vyas SP. Influence of various lipid core on characteristics of SLNs designed for topical delivery of fluconazole against cutaneous candidiasis. Pharm Dev Technol. 2013;18:550.
   PubMed Web of Science ®Google Scholar
• Aggarwal N, Goindi S. Preparation and in vivo evaluation of solid lipid nanoparticles of griseofulvin for dermal use. J Biomed Nanotechnol. 2013;9:564.
   PubMed Web of Science ®Google Scholar
• Vaghasiya H, Kumar A, Sawant K. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. Eur J Pharm Sci. 2013;49:311.
   PubMed Web of Science ®Google Scholar
• Wavikar P, Vavia P. Nanolipidgel for enhanced skin deposition and improved antifungal activity. AAPS PharmSciTech. 2013;14:222.
   PubMed Web of Science ®Google Scholar
• Bhalekar MR, Pokharkar V, Madgulkar A, et al. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech. 2009;10:289.
   PubMed Web of Science ®Google Scholar
• Fernández-Campos F, Naveros B, Serrano O, et al. Evaluation of novel nystatin nanoemulsion for skin candidiasis infections. Mycoses. 2013;56:70.
   PubMed Web of Science ®Google Scholar
• Santos CM, de Oliveira RB, Arantes VT, et al. Amphotericin B-loaded nanocarriers for topical treatment of cutaneous leishmaniasis: development, characterization, and in vitro skin permeation studies. J Biomed Nanotechnol. 2012;8:322.
   PubMed Web of Science ®Google Scholar
• Hussain A, Samad A, Ramzan M, et al. Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation. Drug Deliv. 2016;23(4):1115–1129.
   PubMed Web of Science ®Google Scholar
• Hussain A, Samad A, Singh SK, et al. Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B. Drug Dev Ind Pharm. 2015;41:780.
   PubMed Web of Science ®Google Scholar
• Sampathi S, Mankala SK, Wankar J, et al. Nanoemulsion based hydrogels of itraconazole for transdermal drug delivery. J Scientific Industrial Res. 2015;74:88–92.
   Web of Science ®Google Scholar
• Mahtab A, Anwar M, Mallick N, et al. Transungual delivery of ketoconazole nanoemulgel for the effective management of onychomycosis. AAPS PharmSciTech. 2016;17(6):1477–1490.
   PubMed Web of Science ®Google Scholar
• Elosaily GH, Salem HA, Hassan AM, et al. Formulation, In vitro and In vivo evaluation of nystatin topical gel. J Am Sci. 2014;10:75–85.
   Google Scholar
• De Melo Barbosa R, Finkler CLL, Severino P, et al. Influence of polyethylene glycol-8-lauryl ester in the structural lipid of the elastic liposomes. Afr J Pharm Pharmacol. 2014;8:969–977.
   Google Scholar
• Severino P, Moraes LF, Zanchetta B, et al. Elastic liposomes containing benzophenone-3 for sun protection factor enhancement. Pharm Dev Technol. 2012;17:661.
   PubMed Web of Science ®Google Scholar
• Souto EB. A special issue on lipid-based delivery systems (liposomes, lipid nanoparticles, lipid matrices and medicines). J Biomed Nanotechnol. 2009;5:315
   PubMed Web of Science ®Google Scholar
• Tanrıverdi ST, Özer Ö. Novel topical formulations of terbinafine-HCl for treatment of onychomycosis. Eur J Pharm Sci. 2013;48:628.
   PubMed Web of Science ®Google Scholar
• Verma P, Pathak K. Therapeutic and cosmeceutical potential of ethosomes: an overview. J Adv Pharm Technol Res. 2010;1:274.
   PubMedGoogle Scholar
• Ramalingam P, Ko YT. Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations. Pharm Res. 2015;32:389.
   PubMed Web of Science ®Google Scholar
• Dudhipala N, Veerabrahma K. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Drug Deliv. 2016;23(2):395–404.
   PubMed Web of Science ®Google Scholar
• Souto EB, Doktorovova S. Solid lipid nanoparticle formulations: pharmacokinetic and biopharmaceutical aspects in drug delivery. Methods Enzymol. 2009;464:105–129.
   PubMed Web of Science ®Google Scholar
• Souto EB, Müller RH. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes. Handb Exp Pharmacol. 2010;197:115–141.
   PubMedGoogle Scholar
• Doktorovova S, Souto EB, Silva AM. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – a systematic review of in vitro data. Eur J Pharm Biopharm. 2014;87:1.
   PubMed Web of Science ®Google Scholar
• Souto EB, Doktorovova S. Chapter 6 – solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery. Meth Enzymol. 2009;464:105.
   PubMed Web of Science ®Google Scholar
• Souto EB, Muller RH. Cosmetic features and applications of lipid nanoparticles (SLN®, NLC®). Int J Cosmet Sci. 2008;30:157.
   PubMedGoogle Scholar
• Severino P, Pinho SC, Souto EB, et al. Polymorphism, crystallinity and hydrophilic-lipophilic balance of stearic acid and stearic acid-capric/caprylic triglyceride matrices for production of stable nanoparticles. Colloids Surf B Biointerfaces. 2011;86:125.
   PubMed Web of Science ®Google Scholar
• Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev. 2007;59:478.
   PubMed Web of Science ®Google Scholar
• Souto EB, Muller RH. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes. Handb Exp Pharmacol. 2010; (197):115–41.
   PubMedGoogle Scholar
• Severino P, Pinho SC, Souto EB, et al. Crystallinity of Dynasan®114 and Dynasan®118 matrices for the production of stable Miglyol®-loaded nanoparticles. J Therm Anal Calorim. 2012;108:101.
   Web of Science ®Google Scholar
• Souto EB, Muller RH. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J Microencapsul. 2006;23:377.
   PubMed Web of Science ®Google Scholar
• Ramasamy T, Khandasami US, Ruttala H, et al. Development of solid lipid nanoparticles enriched hydrogels for topical delivery of anti-fungal agent. Macromol Res. 2012;20:682.
   Web of Science ®Google Scholar
• Mohanty B, Majumdar DK, Mishra SK, et al. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery. Pharm Dev Technol. 2015; 20:458.
   PubMed Web of Science ®Google Scholar
• Samein LH. Preparation and evaluation of nystatin loaded-solid-lipid nanoparticles for topical delivery. Int J Pharm Pharm Sci. 2014;6:592–597
   Google Scholar
• Gan L, Wang J, Jiang M, et al. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers. Drug Discov Today. 2013;18:290.
   PubMed Web of Science ®Google Scholar
• Mora-Huertas CE, Garrigues O, Fessi H, et al. Nanocapsules prepared via nanoprecipitation and emulsification-diffusion methods: comparative study. Eur J Pharm Biopharm. 2012;80:235.
   PubMed Web of Science ®Google Scholar
• Junyaprasert VB, Teeranachaideekul V, Souto EB, et al. Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation. Int J Pharm. 2009;377:207.
   PubMed Web of Science ®Google Scholar
• Lu W-C, Chiang B-H, Huang D-W, et al. Skin permeation of D-limonene-based nanoemulsions as a transdermal carrier prepared by ultrasonic emulsification. Ultrason Sonochem. 2014;21:826.
   PubMed Web of Science ®Google Scholar
• Song Z, Sun H, Yang Y, et al. Enhanced efficacy and anti-biofilm activity of novel nanoemulsions against skin burn wound multi-drug resistant MRSA infections. Nanomedicine. 2016;12(6):1543–1555.
   PubMed Web of Science ®Google Scholar